IQVIA Inc. (IQV)
NYSE: IQV
· Real-Time Price · USD
140.93
2.15 (1.55%)
At close: May 29, 2025, 3:59 PM
142.00
0.76%
After-hours: May 29, 2025, 06:00 PM EDT
IQVIA Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Contract Sales And Medical Solutions Revenue | 718M | 727M | 743M | 784M | 741M | 200M | 235M | 3.65B | 3.47B |
| Contract Sales And Medical Solutions Revenue Growth | -1.24% | -2.15% | -5.23% | +5.80% | +270.50% | -14.89% | -93.56% | +5.04% | n/a |
| Research And Development Solutions Revenue | 8.53B | 8.39B | 7.92B | 7.56B | 5.76B | 1.73B | 1.69B | n/a | n/a |
| Research And Development Solutions Revenue Growth | +1.57% | +5.98% | +4.83% | +31.18% | +232.18% | +2.42% | n/a | n/a | n/a |
| Technology And Analytics Solutions Revenue | 6.16B | 5.86B | 5.75B | 5.53B | 4.86B | 1.54B | 1.52B | n/a | n/a |
| Technology And Analytics Solutions Revenue Growth | +5.08% | +2.02% | +3.83% | +13.92% | +214.84% | +1.51% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|
| Americas Revenue | 7.36B | 7.55B | 3.61B | 2.38B | 1.97B | 1.78B | 1.53B |
| Americas Revenue Growth | -2.60% | +109.37% | +51.68% | +20.50% | +10.62% | +16.38% | n/a |
| Asia Pacific Revenue | 3.13B | 2.97B | 1.33B | 931M | 892.93M | 858.28M | 773.86M |
| Asia Pacific Revenue Growth | +5.25% | +122.70% | +43.39% | +4.26% | +4.04% | +10.91% | n/a |
| Emea Revenue | 4.92B | 4.46B | n/a | 2.06B | n/a | n/a | n/a |
| Emea Revenue Growth | +10.34% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 508M | 453M | 522M | 509M | 508M | 556M | 502M | 482M | 513M | 583M | 517M | 483M | 488M | 542M | 498M | 482M | 442M | 491M | 460M | 431M | 407M | 484M | 395M | 436M | 419M | 443M | 429M | 424M | 420M | 464M | 391M | 370M | 380M | 390M | 233.65M | 250.57M | 225.52M | 244.07M | 231.41M | 225.9M | 219.61M |
| Selling, General, and Administrative Revenue Growth | +12.14% | -13.22% | +2.55% | +0.20% | -8.63% | +10.76% | +4.15% | -6.04% | -12.01% | +12.77% | +7.04% | -1.02% | -9.96% | +8.84% | +3.32% | +9.05% | -9.98% | +6.74% | +6.73% | +5.90% | -15.91% | +22.53% | -9.40% | +4.06% | -5.42% | +3.26% | +1.18% | +0.95% | -9.48% | +18.67% | +5.68% | -2.63% | -2.56% | +66.92% | -6.75% | +11.11% | -7.60% | +5.47% | +2.44% | +2.87% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |